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This Article contains errors in the legend of Figure 5.

"(**A**) Systemic zinc chloride (ZnCl~2~; i.p. 1 mg/kg) significantly inhibited NaHS-induced scratching. (**B**) Local application of ZnCl~2~ (i.d. 5 nmol) significantly inhibited NaHS-induced scratching in both RTX- and vehicle-treated mice. (**C**) ZnCl~2~ (i.d. 5 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (**D**) ZnCl~2~(i.pl. 5 nmol) significantly inhibited NaHS-induced flinching. (**E**) Systemic ascorbic acid (Asc; i.p. 1 mg/kg) significantly inhibited NaHS-induced scratching. (**F**) Asc (i.d. 1 nmol) significantly inhibited NaHS-induced scratching in both RTX- and vehicle-treated mice. (**G**) Asc (i.d. 1 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (**H**) Asc (i.pl. 1 nmol) significantly inhibited NaHS-induced flinching. (**I**) Local application of mibefradil (Mib) (i.d. 5--25 nmol) dose-dependently inhibited NaHS-induced scratching in mice. (**J**) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced scratching in RTX-treated mice. (**K**) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (**L**) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced flinching. All data are expressed by means ± SEM. *n* = 6--8 mice per group. \**P* \< 0.05; \*\**P* \< 0.01, \*\*\**P* \< 0.001 vs. vehicle control, Student's *t* test".

should read:

"(**A**) Local application of mibefradil (Mib) (i.d. 5--25 nmol) dose-dependently inhibited NaHS-induced scratching in mice. (**B**) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced scratching in RTX-treated mice. (**C**) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (**D**) Mib (i.d. 10 nmol) significantly inhibited NaHS-induced flinching. (**E**) Systemic zinc chloride (ZnCl2; i.p. 1 mg/kg) significantly inhibited NaHS-induced scratching. (**F**) Local application of ZnCl2 (i.d. 5 nmol) significantly inhibited NaHS-induced scratching in both RTX- and vehicle-treated mice. (**G**) ZnCl2 (i.d. 5 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (**H**) ZnCl2 (i.pl. 5 nmol) significantly inhibited NaHS-induced flinching. (**I**) Systemic ascorbic acid (Asc; i.p. 1 mg/kg) significantly inhibited NaHS-induced scratching. (**J**) Asc (i.d. 1 nmol) significantly inhibited NaHS-induced scratching in both RTX- and vehicle-treated mice. (**K**) Asc (i.d. 1 nmol) significantly inhibited NaHS-induced both forelimb wiping and hindpaw scratching in cheek model. (**L**) Asc (i.pl. 1 nmol) significantly inhibited NaHS-induced flinching. All data are expressed by means ± SEM. *n* = 6--8 mice per group. \**P* \< 0.05; \*\**P* \< 0.01, \*\*\**P* \< 0.001 vs. vehicle control, Student's *t* test".
